Literature DB >> 18060341

The effects of bilateral caudal epidural S2-4 neuromodulation on female sexual function.

Nasim Zabihi1, Arthur Mourtzinos, Mary Grey Maher, Shlomo Raz, Larissa V Rodríguez.   

Abstract

This is a pilot study to evaluate the effects of caudal epidural S2-4 neuromodulation on female sexual function in a population of women with voiding dysfunction. We prospectively studied 36 consecutive female patients who underwent caudal epidural sacral neuromodulation. Patients received the Female Sexual Function Index (FSFI) questionnaire preoperatively and 6 months postoperatively. Six months after permanent implantation, the overall score on the FSFI improved by 52% (p = 0.05). Results were better in patients who underwent the treatment for voiding dysfunction compared to those who had pain as their primary complaint. In this group, the overall score improved by 157% (p = 0.004). Stimulation of S2-4 by bilateral caudal epidural neuromodulation in this small group of women with voiding dysfunction, retention, and/or pelvic pain resulted in self-reported improvements in sexual function. Further studies are needed to evaluate the potential role of S2-4 sacral stimulation in the treatment of female sexual dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 18060341     DOI: 10.1007/s00192-007-0504-8

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  10 in total

1.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.

Authors:  R Rosen; C Brown; J Heiman; S Leiblum; C Meston; R Shabsigh; D Ferguson; R D'Agostino
Journal:  J Sex Marital Ther       Date:  2000 Apr-Jun

Review 2.  The Ferrier lecture, 1986. The actions of parasympathetic and sympathetic nerves in human micturition, erection and seminal emission, and their restoration in paraplegic patients by implanted electrical stimulators.

Authors:  G S Brindley
Journal:  Proc R Soc Lond B Biol Sci       Date:  1988-11-22

3.  Sexual function in women with urinary incontinence.

Authors:  G Aslan; H Köseoğlu; O Sadik; S Gimen; A Cihan; A Esen
Journal:  Int J Impot Res       Date:  2005 May-Jun       Impact factor: 2.896

4.  Sexual function in women attending a urogynecology clinic.

Authors:  D Gordon; A Groutz; T Sinai; A Wiezman; J B Lessing; M P David; D Aizenberg
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1999

5.  Increased vaginal blood flow induced by implant electrical stimulation of sacral anterior roots in the conscious woman: a case study.

Authors:  R J Levin; R P Macdonagh
Journal:  Arch Sex Behav       Date:  1993-10

6.  Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction.

Authors:  Giorgia De Berardis; Fabio Pellegrini; Monica Franciosi; Maurizio Belfiglio; Barbara Di Nardo; Sheldon Greenfield; Sherrie H Kaplan; Maria C E Rossi; Michele Sacco; Gianni Tognoni; Miriam Valentini; Antonio Nicolucci
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

7.  Female sexual response: the role of drugs in the management of sexual dysfunction.

Authors:  R Basson
Journal:  Obstet Gynecol       Date:  2001-08       Impact factor: 7.661

Review 8.  Psychosexual effects of menopause: role of androgens.

Authors:  P M Sarrel
Journal:  Am J Obstet Gynecol       Date:  1999-03       Impact factor: 8.661

9.  Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study.

Authors:  Andrea Salonia; Giuseppe Zanni; Rossella E Nappi; Alberto Briganti; Federico Dehò; Fabio Fabbri; Renzo Colombo; Giorgio Guazzoni; Valerio Di Girolamo; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

10.  Effect of sacral neuromodulation for faecal incontinence on sexual activity.

Authors:  M E D Jarrett; R J Nicholls; M A Kamm
Journal:  Colorectal Dis       Date:  2005-09       Impact factor: 3.788

  10 in total
  8 in total

Review 1.  Sacral neuromodulation and female sexuality.

Authors:  Giuseppe Lombardi; Enrico Finazzi Agrò; Giulio Del Popolo
Journal:  Int Urogynecol J       Date:  2015-04-16       Impact factor: 2.894

Review 2.  Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.

Authors:  Samina Tahseen
Journal:  Int Urogynecol J       Date:  2018-01-04       Impact factor: 2.894

Review 3.  Complaints of micturition, defecation and sexual function in cauda equina syndrome due to lumbar disk herniation: a systematic review.

Authors:  N S Korse; W C H Jacobs; H W Elzevier; C L A M Vleggeert-Lankamp
Journal:  Eur Spine J       Date:  2012-12-13       Impact factor: 3.134

4.  Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit?

Authors:  Michael S Ingber; Ibrahim A Ibrahim; Kim A Killinger; Ananias C Diokno; Kenneth M Peters
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-14

5.  The Impact of Sacral Neuromodulation on Sexual Dysfunction.

Authors:  Pedro Simoes de Oliveira; José Palma Reis; Tiago Ribeiro de Oliveira; David Martinho; Ricardo Pereira E Silva; Joao Marcelino; Sandro Gaspar; Francisco Martins; Tome Lopes
Journal:  Curr Urol       Date:  2019-07-20

Review 6.  Overactive Bladder Syndrome Treatments and Their Effect on Female Sexual Function: A Review.

Authors:  Gali Levy; Lior Lowenstein
Journal:  Sex Med       Date:  2019-10-09       Impact factor: 2.491

7.  Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial.

Authors:  Lingfeng Meng; Zijian Tian; Tongxiang Diao; Miao Wang; Xiaodong Liu; Wei Zhang; Jianye Wang; Yaoguang Zhang
Journal:  Transl Androl Urol       Date:  2021-01

8.  Effect of sacral neuromodulation on female sexual function and quality of life: Are they correlated?

Authors:  Mai Banakhar; Yahya Gazwani; Mohamed El Kelini; Tariq Al-Shaiji; Magdy Hassouna
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.